Literature DB >> 26551085

Induction of CYP2E1 in non-alcoholic fatty liver diseases.

Ghanim Aljomah1, Susan S Baker2, Wensheng Liu1, Rafal Kozielski3, Janet Oluwole1, Benita Lupu1, Robert D Baker1, Lixin Zhu4.   

Abstract

Mounting evidence supports a contribution of endogenous alcohol metabolism in the pathogenesis of non-alcoholic steatohepatitis (NASH). However, it is not known whether the expression of alcohol metabolism genes is altered in the livers of simple steatosis. There is also a current debate on whether fatty acids induce CYP2E1 in fatty livers. In this study, expression of alcohol metabolizing genes in the liver biopsies of simple steatosis patients was examined by quantitative real-time PCR (qRT-PCR), in comparison to biopsies of NASH livers and normal controls. Induction of alcohol metabolizing genes was also examined in cultured HepG2 cells treated with ethanol or oleic acid, by qRT-PCR and Western blots. We found that the mRNA expression of alcohol metabolizing genes including ADH1C, ADH4, ADH6, catalase and CYP2E1 was elevated in the livers of simple steatosis, to similar levels found in NASH livers. In cultured HepG2 cells, ethanol induced the expression of CYP2E1 mRNA and protein, but not ADH4 or ADH6; oleic acid did not induce any of these genes. These results suggest that elevated alcohol metabolism may contribute to the pathogenesis of NAFLD at the stage of simple steatosis as well as more severe stages. Our in vitro data support that CYP2E1 is induced by endogenous alcohol but not by fatty acids.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CYP2E1; NAFLD; NASH; Simple steatosis

Mesh:

Substances:

Year:  2015        PMID: 26551085      PMCID: PMC4679539          DOI: 10.1016/j.yexmp.2015.11.008

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  27 in total

1.  Histopathology of pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J Schork; Joel E Lavine
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

Review 2.  Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress.

Authors:  G Robertson; I Leclercq; G C Farrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-11       Impact factor: 4.052

3.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

Authors:  Lixin Zhu; Susan S Baker; Chelsea Gill; Wensheng Liu; Razan Alkhouri; Robert D Baker; Steven R Gill
Journal:  Hepatology       Date:  2013-01-08       Impact factor: 17.425

4.  Nonalcoholic fatty liver disease as a comorbidity of childhood obesity.

Authors:  Nicole J Barshop; Cameron S Francis; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Ped Health       Date:  2009-06-01

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 6.  Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease.

Authors:  M Ingelman-Sundberg; I Johansson; H Yin; Y Terelius; E Eliasson; P Clot; E Albano
Journal:  Alcohol       Date:  1993 Nov-Dec       Impact factor: 2.405

7.  Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers.

Authors:  Ruixin Zhu; Susan S Baker; Cynthia A Moylan; Manal F Abdelmalek; Cynthia D Guy; Fausto Zamboni; Dingfeng Wu; Weili Lin; Wensheng Liu; Robert D Baker; Sugantha Govindarajan; Zhiwei Cao; Patrizia Farci; Anna Mae Diehl; Lixin Zhu
Journal:  J Pathol       Date:  2016-01-29       Impact factor: 7.996

Review 8.  Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.

Authors:  Chin Hee Kim; Zobair M Younossi
Journal:  Cleve Clin J Med       Date:  2008-10       Impact factor: 2.321

9.  Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA.

Authors:  T Takahashi; J M Lasker; A S Rosman; C S Lieber
Journal:  Hepatology       Date:  1993-02       Impact factor: 17.425

10.  Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease.

Authors:  Sonia Michail; Malinda Lin; Mark R Frey; Rob Fanter; Oleg Paliy; Brian Hilbush; Nicholas V Reo
Journal:  FEMS Microbiol Ecol       Date:  2014-12-05       Impact factor: 4.519

View more
  15 in total

1.  Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress.

Authors:  Youngshim Choi; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  Food Chem Toxicol       Date:  2017-03-01       Impact factor: 6.023

Review 2.  Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.

Authors:  Enoch Cobbina; Fatemeh Akhlaghi
Journal:  Drug Metab Rev       Date:  2017-03-17       Impact factor: 4.518

3.  Liver kinase B1/AMP-activated protein kinase-mediated regulation by gentiopicroside ameliorates P2X7 receptor-dependent alcoholic hepatosteatosis.

Authors:  Xia Li; Yu Zhang; Quan Jin; Kai-Li Xia; Min Jiang; Ben-Wen Cui; Yan-Ling Wu; Shun-Zong Song; Li-Hua Lian; Ji-Xing Nan
Journal:  Br J Pharmacol       Date:  2018-03-09       Impact factor: 8.739

4.  Toxicological Implications of Mitochondrial Localization of CYP2E1.

Authors:  Jessica H Hartman; Grover P Miller; Joel N Meyer
Journal:  Toxicol Res (Camb)       Date:  2017-03-14       Impact factor: 3.524

5.  Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma.

Authors:  Deyu Zhang; Jiahong Liu; Tian Xie; Qiwei Jiang; Lihua Ding; Jianhua Zhu; Qinong Ye
Journal:  Int J Biol Sci       Date:  2020-08-27       Impact factor: 6.580

6.  Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway.

Authors:  Ting Zhai; Wei Xu; Yayun Liu; Kun Qian; Yanling Xiong; Yong Chen
Journal:  Oxid Med Cell Longev       Date:  2020-11-27       Impact factor: 6.543

7.  ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis.

Authors:  Torsten Diesinger; Alfred Lautwein; Vyacheslav Buko; Elena Belonovskaya; Oksana Lukivskaya; Elena Naruta; Siarhei Kirko; Viktor Andreev; Radovan Dvorsky; Dominik Buckert; Sebastian Bergler; Christian Renz; Dieter Müller-Enoch; Thomas Wirth; Thomas Haehner
Journal:  Physiol Rep       Date:  2021-03

Review 8.  Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications.

Authors:  Shiyao Zhang; Mengyi Xu; Wenxiang Zhang; Chang Liu; Siyu Chen
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

9.  Resveratrol Ameliorates Experimental Alcoholic Liver Disease by Modulating Oxidative Stress.

Authors:  He Peiyuan; Hou Zhiping; Song Chengjun; Wang Chunqing; Li Bingqing; Mustapha Umar Imam
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

10.  Hepatoprotective Effect of Loquat Leaf Flavonoids in PM2.5-Induced Non-Alcoholic Fatty Liver Disease via Regulation of IRs-1/Akt and CYP2E1/JNK Pathways.

Authors:  Tunyu Jian; Xiaoqin Ding; Yuexian Wu; Bingru Ren; Weilin Li; Han Lv; Jian Chen
Journal:  Int J Mol Sci       Date:  2018-10-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.